Authors: Sacchi, S Federico, M Vitolo, U Boccomini, C Vallisa, D Baldini, L Petrini, M Rupoli, S Di Raimondo, F Merli, F Liso, V Tabilio, A Saglio, G Vinci, G Brugiatelli, M Dastoli, G

Citation: S. Sacchi et al., Clinical activity and safety of combination immunotherapy with interferon-alpha 2a and rituximab in patients with relapsed low grade non-Hodgkin's lymphoma, HAEMATOLOG, 86(9), 2001, pp. 951-958

Authors: Marmont, F Allione, B Audisio, E Boccomini, C Ciocca, V D'Ardia, S Falda, M Locatelli, F Gallo, E

Citation: F. Marmont et al., A landmark analysis of survival by response category in elderly patients with acute myeloblastic leukemia, HEMAT BLOOD, 40, 2001, pp. 644-646

Authors: Federico, M Vitolo, U Zinzani, PL Chisesi, T Clo, V Bellesi, G Magagnoli, M Liberati, M Boccomini, C Niscola, P Pavone, V Cuneo, A Santini, G Brugiatelli, M Baldini, L Rigacci, L Resegotti, L

Citation: M. Federico et al., Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases, BLOOD, 95(3), 2000, pp. 783-789

Authors: Calvi, R Bertini, M Boccomini, C Botto, B Orsucci, L Vitolo, U

Citation: R. Calvi et al., Burkitt's lymphomas in adults: retrospective analysis of 30 cases treated with two different schemes, HAEMATOLOG, 84(4), 1999, pp. 383-384